Pancreatitis Trial, Recruiting NCT06967701 Sponsor: Yale University Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT06967701
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 30 and 65 years old (inclusive)
  • You have been diagnosed with type 1 diabetes, or a related condition where the body does not make enough insulin (such as a slow-onset form of type 1 diabetes in adults, or diabetes caused by pancreatitis)
  • You currently exercise less than once per week on average
  • You own a smartphone
  • You can read and write in English
  • You see a healthcare provider at least once a year
  • You have access to home broadband internet or a mobile phone network
  • You have been using a continuous glucose monitor (a device that tracks your blood sugar throughout the day) and your data has been shared with your medical records for at least 6 weeks
  • You have been using an insulin pump or insulin pen and your data has been shared with your medical records for at least 6 weeks

Who may not be able to join:

  • You have had a serious diabetes-related emergency (called diabetic ketoacidosis) in the past 6 months that was not clearly caused by a pump site failure
  • You have had more than one episode of severely low blood sugar requiring help from another person in the past 6 months
  • Your average blood sugar control (measured by an A1c blood test) is 10.0% or higher
  • Your resting blood pressure is too high (above 160/100 mmHg)
  • You have had a heart attack or chest pain (angina) in the past 12 months
  • You have an uncontrolled irregular heart rhythm (confirm with trial site)
  • You have advanced heart failure (stage 3 or 4)
  • You have exercise-induced asthma that is not controlled with inhalers
  • You have a serious lung condition that requires you to use oxygen at home
  • You have kidney failure
  • You are pregnant
  • You have a condition that affects your thinking, memory, or understanding
  • You have severe damage to your eyes or nerves related to diabetes
  • You have another long-term illness or physical limitation that could affect your ability to exercise (for example, recent spinal surgery)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Garrett Ash, PhD, CSCS, Yale University

Phone: 203-444-0678

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
10 July 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Weekly exercise duration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov